Literature DB >> 19672898

EAE: an immunologist's magic eye.

Gurumoorthy Krishnamoorthy1, Hartmut Wekerle.   

Abstract

EAE comes in many shapes and colors. Individual variants of EAE present a baffling complexity of different aspects and traits, clinical, immunological, and structural. But, embedded in this seemingly chaotic image, the educated eye will discern patterns that retrace fundamental features of immune response, in particular, autoimmunity and self-tolerance. EAE and its variants thus can be likened to an autostereogram, i.e. they are an immunologist's magic eye.

Entities:  

Mesh:

Year:  2009        PMID: 19672898     DOI: 10.1002/eji.200939568

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  40 in total

Review 1.  CXCL12 in control of neuroinflammation.

Authors:  Miljana Momcilović; Marija Mostarica-Stojković; Djordje Miljković
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 2.  The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.

Authors:  Jeffery J Auletta; Amelia M Bartholomew; Richard T Maziarz; Robert J Deans; Robert H Miller; Hillard M Lazarus; Jeffrey A Cohen
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

Review 3.  Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.

Authors:  Robert H Miller; Sharyl L Fyffe-Maricich
Journal:  Dis Model Mech       Date:  2010-07-20       Impact factor: 5.758

4.  Ophthalmopathology in rats with MBP-induced experimental autoimmune encephalomyelitis.

Authors:  Oliver W Gramlich; Stephanie C Joachim; Philip F Gottschling; Panagoitis Laspas; Clemens S Cuny; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-02-23       Impact factor: 3.117

Review 5.  Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury.

Authors:  Tobias Derfuss; Chris Linington; Reinhard Hohlfeld; Edgar Meinl
Journal:  J Mol Med (Berl)       Date:  2010-05-06       Impact factor: 4.599

6.  ZSTK474, a novel PI3K inhibitor, modulates human CD14+ monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.

Authors:  Zhenyi Xue; Wen Li; Huafeng Wang; Biao Huang; Zhenzhen Ge; Chao Gu; Ying Liu; Kai Zhang; Juhong Yang; Rong Han; Meiyu Peng; Yan Li; Da Zhang; Yurong Da; Zhi Yao; Rongxin Zhang
Journal:  J Mol Med (Berl)       Date:  2014-05-22       Impact factor: 4.599

7.  ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood-brain barrier.

Authors:  Ruth Lyck; Marc-André Lécuyer; Michael Abadier; Christof B Wyss; Christoph Matti; Maria Rosito; Gaby Enzmann; Thomas Zeis; Laure Michel; Ana B García Martín; Federica Sallusto; Fabien Gosselet; Urban Deutsch; Joshua A Weiner; Nicole Schaeren-Wiemers; Alexandre Prat; Britta Engelhardt
Journal:  J Cereb Blood Flow Metab       Date:  2016-11-14       Impact factor: 6.200

8.  ATG-dependent phagocytosis in dendritic cells drives myelin-specific CD4+ T cell pathogenicity during CNS inflammation.

Authors:  Christian W Keller; Christina Sina; Monika B Kotur; Giulia Ramelli; Sarah Mundt; Isaak Quast; Laure-Anne Ligeon; Patrick Weber; Burkhard Becher; Christian Münz; Jan D Lünemann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-12       Impact factor: 11.205

9.  Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans.

Authors:  Boris Calderon; Javier A Carrero; Mark J Miller; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

Review 10.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.